Insider · CIK 0001767807

SABESAN VIJAY

Reports to the SEC for 1 company · SOUTH SAN FRANCISCO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001767807

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-11-19	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, TECHNICAL OPERATIONS	FTax Payment	−5,191 sh	$8.36	−$43.4K	235,524
2021-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, TECHNICAL OPERATIONS	FTax Payment	−5,193 sh	$14.05	−$73K	240,715
2021-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, TECHNICAL OPERATIONS	FTax Payment	−5,194 sh	$17.80	−$92.5K	245,908
2021-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, TECHNICAL OPERATIONS	FTax Payment	−8,343 sh	$18.79	−$157K	249,701
2021-02-08	TBPHTheravance Biopharma, Inc.A Award	SVP, TECHNICAL OPERATIONS	AAward	+65K sh	—	—	258,044
2020-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, TECHNICAL OPERATIONS	FTax Payment	−3,798 sh	$17.21	−$65.4K	193,044
2020-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, TECHNICAL OPERATIONS	FTax Payment	−3,799 sh	$18.22	−$69.2K	196,842
2020-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, TECHNICAL OPERATIONS	FTax Payment	−3,801 sh	$26.67	−$101K	200,641
2020-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, TECHNICAL OPERATIONS	FTax Payment	−7,213 sh	$25.90	−$187K	203,040
2020-02-03	TBPHTheravance Biopharma, Inc.A Award	SVP, TECHNICAL OPERATIONS	AAward	+65K sh	—	—	210,253
2019-12-12	TBPHTheravance Biopharma, Inc.S Sale	SVP, TECHNICAL OPERATIONS	SSale	−1,027 sh	$21.03	−$21.6K	145,253
2019-11-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, TECHNICAL OPERATIONS	FTax Payment	−1,473 sh	$17.60	−$25.9K	146,280
2019-08-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, TECHNICAL OPERATIONS	FTax Payment	−1,472 sh	$21.51	−$31.7K	147,753
2019-05-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, TECHNICAL OPERATIONS	FTax Payment	−1,474 sh	$19.84	−$29.2K	149,225
2019-02-20	TBPHTheravance Biopharma, Inc.F Tax Payment	SVP, TECHNICAL OPERATIONS	FTax Payment	−4,568 sh	$27.00	−$123K	149,672

Recent filings

Accepted (ET)
Nov 234
SABESAN VIJAY0001415889-21-005464
SEC(opens sec.gov)
Aug 244
SABESAN VIJAY0001179110-21-008400
SEC(opens sec.gov)
May 244
SABESAN VIJAY0001179110-21-005848
SEC(opens sec.gov)
Feb 234
SABESAN VIJAY0001179110-21-002171
SEC(opens sec.gov)
Feb 104
SABESAN VIJAY0001179110-21-001539
SEC(opens sec.gov)
Nov 244
SABESAN VIJAY0001179110-20-011373
SEC(opens sec.gov)
Aug 244
SABESAN VIJAY0001179110-20-009271
SEC(opens sec.gov)
May 224
SABESAN VIJAY0001179110-20-006530
SEC(opens sec.gov)
Feb 244
SABESAN VIJAY0001179110-20-002152
SEC(opens sec.gov)
Feb 54
SABESAN VIJAY0001179110-20-001206
SEC(opens sec.gov)
Dec 164
SABESAN VIJAY0001179110-19-012848
SEC(opens sec.gov)
Nov 224
SABESAN VIJAY0001179110-19-012019
SEC(opens sec.gov)
Aug 224
SABESAN VIJAY0001179110-19-009794
SEC(opens sec.gov)
May 224
SABESAN VIJAY0001179110-19-006530
SEC(opens sec.gov)
Feb 224
SABESAN VIJAY0001179110-19-002427
SEC(opens sec.gov)

Companies

Theravance Biopharma, Inc.SVP, TECHNICAL OPERATIONSTBPH

Address

C/O THERAVANCE BIOPHARMA US, INC. 901 GATEWAY BLVD

SOUTH SAN FRANCISCO, CA, 94080